Lisa Elliott

Observer
DISC Type : ic

VP Global Asset and Product Strategy at LEO Pharma

Copenhagen, Capital Region of Denmark, Denmark

Overview

Lisa Elliott is the VP of Global Asset and Payer Strategy at LEO Pharma, with over 15 years of experience in market access. Her expertise covers global pricing, HEOR, and RWE strategy across all phases of drug development. She holds a PhD from UNSW and a degree in Medical Science.

As interim EVP of Global Product Strategy, Lisa led a division of over 450 people, overseeing functions from Brand Teams and Medical Affairs to Commercial Analytics.

Personality Overview

Curious

Example Seeker

Value Driven

They ask a lot of questions and rely heavily on information and collaterals.  They can sound friendly and charming but can quickly change gears to become inquisitive and probing. They are generally good communicators and can be hard to convince.

Topics They Care About

Market Access Strategy
Her entire career and current role focuses on global market access, covering all phases of drug development from early-stage assets to established brands.
HEOR & RWE
She leads the Health Economics & Outcomes Research (HEOR) and Real-World Evidence (RWE) strategy, generation, and implementation at a global level.
Talent Development
Frequently posts about hiring for her teams, including market access, HEOR, and digital, indicating a focus on building a strong organization.

Media Appearances

To sharpen focus on the global commercialization of strategic products and the external partnership model, LEO Pharma makes changes to leadership. Featured in Ritzau

See Now

2025 Management changes | LEO Pharma. Featured in LEO Pharma (official website)

See Now

Executive changes at LEO Pharma. Featured in MedAdNews

See Now

Work History

2-2026
VP Global Asset and Product Strategy at LEO Pharma
5-2025 - 2-2026
EVP Global Product Strategy - interim at LEO Pharma
9-2024 - 2-2026
VP Global Asset and Payer Strategy at LEO Pharma
10-2022 - 9-2024
Vice President of Global Pricing, HEOR, Market Access and New Product Planning at LEO Pharma
2-2022 - 10-2022
Head of Global Strategic Pricing, HEOR&RWE and Market Access at LEO Pharma

Education

2003 - 2005
PhD from UNSW
1999 - 2002
Medical science (Hons) from University of Technology Sydney

More Information

Social Presence :

Prographics :

Exp : 20 Location : Copenhagen, Capital Region of Denmark, Denmark Job Level : Senior Designation : VP Global Asset and Product Strategy at LEO Pharma
URL has been copied!

Insights For Selling To Lisa

During A Call Or A Meeting

DO's

  • Help them understand the risk aspect fully while inspiring confidence
  • Be prepared for a lot of questions, answer them objectively
  • Persuade objectively how your product will help them achieve their goals

DONT's

  • Don’t brush off any concerns, take all questions seriously
  • Don’t rely excessively on your relationship with them to win the deal
  • Don’t be too objective but make sure to pad your storytelling with data points

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Lisa is

  • Proven value, strong testimonials are important for them, rapport can impact decisions a little.
  • Will you ever get a clear answer from Lisa

  • They are practical and friendly, don't expect a clear-cut response often.

Insights For Deal Planning

    How fast (or slow) will Lisa move?

  • They like to be detailed and take their time to arrive at decisions.
  • Can Lisa take some risk or not?

  • They weigh all decisions systematically and are unlikely to take many risks.

You And Lisa

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.